Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that the first patient ...

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) investors will be delighted, with the company turning in some strong numbers with its latest results. Overall results were decent, with revenues of US$1 ...

The way the city is located on the map is with a latitude and a longitude. Similarly, on a plane, Cartesian coordinates use a pair of numbers – one on the x-axis, one on the y-axis – that can ...

Descartes-08, Cartesian’s lead mRNA cell therapy candidate and a potential first-in-class mRNA-engineered chimeric antigen receptor T-cell therapy (mRNA CAR-T), is an autologous mRNA CAR-T ...

May 08, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today reported ...

GAITHERSBURG, Md., Sept. 1, 2020 /PRNewswire/ -- Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company developing cell and gene therapies for cancer, autoimmune diseases ...

“Snakes on a Cartesian Plane” is a free Flash game that offers a whopping 28 variations on the cellphone classic, “Snake.” “Snakes on a Cartesian Plane” is a free Flash game that ...

Dosing Continues in First-in-Human Phase 1 Clinical Trial of Descartes-15. The Phase 1 dose escalation trial of Cartesian’s next-generation, autologous anti-BCMA CAR-T cell therapy, is designed ...

Sept. 03, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today ...